185 related articles for article (PubMed ID: 24086767)
1. Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.
Olli S; Rangaraj N; Nagaraj R
PLoS One; 2013; 8(9):e77031. PubMed ID: 24086767
[TBL] [Abstract][Full Text] [Related]
2. Engineering of a linear inactive analog of human β-defensin 4 to generate peptides with potent antimicrobial activity.
Sharma H; Mathew B; Nagaraj R
J Pept Sci; 2015 Jun; 21(6):501-11. PubMed ID: 25810238
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
Krishnakumari V; Singh S; Nagaraj R
Peptides; 2006 Nov; 27(11):2607-13. PubMed ID: 16860904
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of human β-defensin 4 analogs: insights into the role of disulfide linkages in modulating activity.
Sharma H; Nagaraj R
Peptides; 2012 Dec; 38(2):255-65. PubMed ID: 23000475
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.
Krishnakumari V; Rangaraj N; Nagaraj R
Antimicrob Agents Chemother; 2009 Jan; 53(1):256-60. PubMed ID: 18809937
[TBL] [Abstract][Full Text] [Related]
6. A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.
Olli S; Nagaraj R; Motukupally SR
Antimicrob Agents Chemother; 2015 Jan; 59(1):217-25. PubMed ID: 25348533
[TBL] [Abstract][Full Text] [Related]
7. N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance.
Li T; Guo F; Wang Q; Fang H; Li Z; Wang D; Wang H
PLoS One; 2015; 10(2):e0117913. PubMed ID: 25706284
[TBL] [Abstract][Full Text] [Related]
8. Two arginine residues in the COOH-terminal of human β-defensin-3 constitute an essential motif for antimicrobial activity and IL-6 production.
Sakagami-Yasui Y; Shirafuji Y; Yamasaki O; Morizane S; Hamada T; Umemura H; Iwatsuki K
Exp Dermatol; 2017 Nov; 26(11):1026-1032. PubMed ID: 28418601
[TBL] [Abstract][Full Text] [Related]
9. Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.
Sharma H; Nagaraj R
PLoS One; 2015; 10(3):e0119525. PubMed ID: 25785690
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of three beta-defensins from canine testes.
Sang Y; Ortega MT; Blecha F; Prakash O; Melgarejo T
Infect Immun; 2005 May; 73(5):2611-20. PubMed ID: 15845463
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of human α-defensin 6 analogs: insights into the physico-chemical reasons behind weak bactericidal activity of HD6 in vitro.
Mathew B; Nagaraj R
J Pept Sci; 2015 Nov; 21(11):811-8. PubMed ID: 26400692
[TBL] [Abstract][Full Text] [Related]
12. N-Terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine β-defensin-2 results in salt-resistant antibacterial activity.
Krishnakumari V; Nagaraj R
Biophys Chem; 2015 Apr; 199():25-33. PubMed ID: 25791057
[TBL] [Abstract][Full Text] [Related]
13. The influence of isoleucine and arginine on biological activity and peptide-membrane interactions of antimicrobial peptides from the bactericidal domain of AvBD4.
Hu WN; Jiao WJ; Ma Z; Dong N; Ma QQ; Shao CX; Shan AS
Protein Pept Lett; 2013 Nov; 20(11):1189-99. PubMed ID: 23746111
[TBL] [Abstract][Full Text] [Related]
14. Large-scale synthesis and functional elements for the antimicrobial activity of defensins.
Raj PA; Antonyraj KJ; Karunakaran T
Biochem J; 2000 May; 347 Pt 3(Pt 3):633-41. PubMed ID: 10769165
[TBL] [Abstract][Full Text] [Related]
15. Toward understanding the cationicity of defensins. Arg and Lys versus their noncoded analogs.
Zou G; de Leeuw E; Li C; Pazgier M; Li C; Zeng P; Lu WY; Lubkowski J; Lu W
J Biol Chem; 2007 Jul; 282(27):19653-65. PubMed ID: 17452329
[TBL] [Abstract][Full Text] [Related]
16. Human beta-defensin-3: a promising antimicrobial peptide.
Batoni G; Maisetta G; Esin S; Campa M
Mini Rev Med Chem; 2006 Oct; 6(10):1063-73. PubMed ID: 17073706
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Activity of Snake β-Defensins and Derived Peptides.
Oguiura N; Corrêa PG; Rosmino IL; de Souza AO; Pasqualoto KFM
Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050978
[TBL] [Abstract][Full Text] [Related]
18. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.
Scudiero O; Galdiero S; Cantisani M; Di Noto R; Vitiello M; Galdiero M; Naclerio G; Cassiman JJ; Pedone C; Castaldo G; Salvatore F
Antimicrob Agents Chemother; 2010 Jun; 54(6):2312-22. PubMed ID: 20308372
[TBL] [Abstract][Full Text] [Related]
19. Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.
Yang M; Zhang C; Zhang X; Zhang MZ; Rottinghaus GE; Zhang S
BMC Microbiol; 2016 Sep; 16(1):210. PubMed ID: 27613063
[TBL] [Abstract][Full Text] [Related]
20. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.
Vylkova S; Nayyar N; Li W; Edgerton M
Antimicrob Agents Chemother; 2007 Jan; 51(1):154-61. PubMed ID: 17074797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
